|
|
||||||||
US Department of Agriculture, Beltsville, MD 20705
Abstract
Ovulation time of gilts was controlled by oral treatment with altrenogest (17-allyl-hydroxy-estra-4,9,ll-trien-3-one) followed by gonado tropic hormone injections. Gilts were laparotomized 42 to 44 h after injection of human chorionic gonadotropin. Spermatozoa were surgically placed into ligated oviducts of gilts after one of the following semen treatments: frozen and thawed in Beltsville thawing solution (F-BTS) or in seminal plasma (F-SP); unfrozen, processed like the frozen semen, but not cooled, frozen or thawed, and extended in Beltsville thawing solution (U-BTS) or in seminal plasma (U-SP). Ova were recovered 5 or 24 h after insemination and their stage of development was determined. At 5 h, F-BTS and U-BTS spermatozoa had fertilized significantly more ova (45 and 69%, respectively) than the F-SP and U-SP spermatozoa (5 and 34%, respectively). Ova fertilized by F-BTS and U-BTS spermatozoa had reached a more advanced stage of development than ova fertilized by F-SP and U-SP spermatozoa at both recovery times. Unfrozen spermatozoa (U-BTS or U-SP) fertilized more ova by 5 h after tubal deposition than F-BTS or F-SP spermatozoa (P<.005 for each comparison). By 24 h, the percentage of fertilized ova was similar for all treatments. The results indicate that semen processing reduced capacitation time of boar spermatozoa to an extent similar to passage through the uterus. The capacitation time of frozen thawed spermatozoa appeared to be similar to spermatozoa that were processed, but not cooled, frozen or thawed.
1 I wish to acknowledge Leah Schulman for skilled technical assistance, Linda Neuenhahn for typing the manuscript and Dr. S. K. Webel, Reproductive Consulting Service, McHenry, IL, and The Roussel-UCLAF Co., Paris, France, for supplying altrenogest.
2 ARS, Beltsville Agr. Res. Center, Reprod. Lab.
3 Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the USDA and does not imply its approval to the exclusion of other products that may be suitable.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |